Volcano Takes Advantage Of Competitors' Trials To Tout FFR, IVUS
This article was originally published in The Gray Sheet
Executive Summary
Intravascular imaging device-maker Volcano is talking up the results of two trials presented at the TCT conference, although it was not the primary sponsor of either of them
You may also be interested in...
St. Jude Diversifies In Intra-Coronary Assessment Market With $90 Mil. Buy
St. Jude Medical is upping the ante in the coronary lesion assessment space with the $90 million cash acquisition of LightLab Imaging
St. Jude Diversifies In Intra-Coronary Assessment Market With $90 Mil. Buy
St. Jude Medical is upping the ante in the coronary lesion assessment space with the $90 million cash acquisition of LightLab Imaging
Lift-Off Time For LipiScan? Data And Payment Policies Will Tell
InfraReDx is in the final planning stages for its first randomized trial to secure a place for its LipiScan intracoronary imaging device in clinical practice